Premium
Retrospective evaluation of the use of hydrocortisone for treatment of suspected critical illness–related corticosteroid insufficiency (CIRCI) in dogs with septic shock (2010–2017): 47 cases
Author(s) -
Summers April M.,
Culler Christine,
Yaxley Page E.,
Guillaumin Julien
Publication year - 2021
Publication title -
journal of veterinary emergency and critical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 47
eISSN - 1476-4431
pISSN - 1479-3261
DOI - 10.1111/vec.13037
Subject(s) - medicine , septic shock , corticosteroid , bolus (digestion) , blood pressure , shock (circulatory) , hydrocortisone , anesthesia , retrospective cohort study , surgery , gastroenterology , sepsis
Objective To evaluate characteristics of septic shock patients treated with hydrocortisone (HC) due to suspicion of critical illness–related corticosteroid insufficiency (CIRCI) as compared to septic shock patients without suspicion of CIRCI. Design Retrospective study between February 2010 and October 2017. Setting University teaching hospital ICU. Animals Data were collected for 47 dogs with septic shock. Twenty‐one dogs were treated with HC (HC‐treated) due to suspicion of CIRCI. Twenty‐six dogs did not receive HC (non‐HC‐treated). Interventions HC was administered either as an intermittent IV bolus or as a constant rate infusion (CRI) to those patients with suspected CIRCI. Measurements and main results Significantly higher baseline APPLE full scores and predicted mortality were detected in the HC‐treated patients compared to non‐HC‐treated patients (0.87 vs 0.44 for predicted mortality, P = 0.039). Patients in the HC‐treated group were on more vasopressors and cardiotonics than those in the non‐HC‐treated group (2.5 vs 1.5, P <0 .001). All patients initially responded to vasopressor administration, with average time to resolution of hypotension being 90 minutes for the HC‐treated group compared to 60 minutes for the non‐HC‐treated group ( P = 0.640). However, HC‐treated patients took significantly longer to have a sustained resolution (a systolic blood pressure > 90 mm Hg or a mean blood pressure > 65 mm Hg for at least 4 h) of their hypotension after starting vasopressors, as compared to their non‐HC‐treated counterparts (8.5 vs 4 h, P = 0.001). Three (14.3%) HC‐treated patients survived to discharge compared to 9 (34.6%) non‐HC‐treated patients, but this was not statistically significant. Conclusions HC‐treated patients had a higher baseline risk of mortality than non‐HC‐treated patients. There was no significant difference in survival between the HC‐treated and non‐HC‐treated septic shock patients. Further studies are needed to evaluate the use of HC in patients with suspected CIRCI.